{"ticker": {"uuid": "31f0ee0e-c758-45be-bdd7-2e364f09c089", "symbol": "IBX", "name": "Imagion Biosystems Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Is Imagion Biosystems Ltd (ASX: IBX) an ASX MedTech Stock to Watch?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNd0R6aDlUVHphVnZZNmtoODlWU3NrcFMzZ19iVEprQkhONTJrdXhLaXA2aDNhOTVvT3RDZTBTZ1JIVWFwT25qOTBxYVBwNk5ZbmRsNlVtMTF0Z0hmWlJiZ2pjM2l0TGFPSmVDeG81dl9xbTNwYy1yaEdONHdtQ2hnZUpjV1ZnUEFTNDdRNWQ3NVVucC13Y0lPckRTcjRaV25FOUN3VQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T03:26:00+00:00", "published_display": "14 Jul 2026 03:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Raises AU$3.75M; Extends Siemens Partnership to Advance Breast Cancer Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOd1NKQW9vV3p0ZmZ0OGZxR21KdlpqMUNPdjlORG9NN3UydHRUck9tZm1MU2ItcVdBbGVHRnE5WFRxRTc0R0JKOGxmeEpGdERhcHpfVl95b0NacVBGWkxtYXEzTGVIUnZDT1dTT2Rld3RWZ1FyTnJBb3hXbVktcWRRUzVlX3VmaWFzMFhCY0Y2OVdpSFQ3cTVfUEU4NnlOd3RVSk1kOTR4d005X3NOTzlBcUtGVGV5NzlNZ0VfTA?oc=5", "source_name": "Femtech Insider", "published_at": "2026-07-10T06:38:56+00:00", "published_display": "10 Jul 2026 06:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Completes Placement of 49.3 Million Shares at $0.012, Bringing Total Ordinary Shares on Issue to 539.9 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxNNi05SU1rejFkbzh5ZnJpeDFyRGZnWEtGdzhtTGJGUW51cTc3b0h5QVZia25YUV9Cd3k0X3EzSENDMWdPeTkwN3NJMlNnaUtBX1BwdThRcWktc2h4WWNXb3hFeW9lRUphbmxwb0RVV0I1SWFKZVhkYUZRUEtiRXZvZlp6dDlYWjA4UFk0dTdNZjBxZnQtd3VEVE1pbkt3QkdNTDVULVU4Q0loeDF3aDNoRnF5NVJMSkhxZTl0Zk1zQWxvOE45OUh3c1I4dU9rU1lpbTNSdkd3U3RHOWo1NFBkVVVOTnl1OWx1N3N0ejU2ZVpfMWtBRWNhRWJR?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Issues 49.3 Million Shares at 1.2 Cents Each in Tranche 1 Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNVlM2QTVjQzZvR3h4ZWlMc3plc3ZCLVJwd3RDR1g2VjdWdFNNb0QwZVFRemZ2TS1vSlBrYmhHdkgzQlI0c0xiX1VsdjhXUklXQzZHX3JpdVNndUtfOUdBUlptYUxyakR3S0FaMUlFUGxKOU9uZVZ3VFlNeV9JSkZDbW1pamxhdVZmV3RMYnlBUjJFMzlYckVsTTJHdmZMUThTZXd4V0xnZ1BqWWVMUmNIT2pkSy1OSjU3a0ptemdaSmhQc2Jy?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T05:26:40+00:00", "published_display": "02 Jul 2026 05:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Imagion Biosystems (ASX:IBX) Attracting Medtech Investors?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPQ0ptdmM5T2NBT1ZlVmF3Z2xlUkphU0V6eHdPeEIwd0wtU1JHVTNqNXhLT09kM2RmVmgtcFUzNE83bUxHZnhaNGc1QzBBRFd6cnplR0FQMlBud2wxNjVpaG4tRUE1bTJpTTQ0QTluUVVUWFotZ2xNRzhvalMwZXB4b1JMdERPODZsWlRETE9CLWJOeXV4cndhN0psdE1zQ01OVG1Seg?oc=5", "source_name": "Kalkine", "published_at": "2026-06-29T13:49:00+00:00", "published_display": "29 Jun 2026 13:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Secures AU$3.75 Million Capital Raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNSjJQdVp0TFBJdVRfS2c5N0RlWXpFNjlENk1tZy1BU29pT1AwTUlhT2JPWDlzUW5ILVQ0cUJhSlBPUzRBckdhYjN5eDZPaDc1ZHVFa01WNEktR3NMWlFTYzk4N2tWQjRnMTVXLVltUVJGY1dTeDluTFFrMVk1bHBvUtIBhgFBVV95cUxQV2NSdmp5Z3VibW12cm1ZZGluME1wYW9CX29YVV9qdmx3QjNCOENPTEZ2dGtrVGY0TnVoMDFiQVZoYnRFTVhwMkhjaVUzZ2V0bzhORlFueklvNG04M2hWRk04VGxVblZwWVppTU04bjY2c2psQkVfampxT0U0bDhEZFlRNVd5UQ?oc=5", "source_name": "Pulse 2.0", "published_at": "2026-06-26T12:23:12+00:00", "published_display": "26 Jun 2026 12:23", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems raises AU$3.75M for breast cancer trial By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVlFFR1ZQWlNUd0NNWkFKWnZSbVFQX2VMb1hySjA2UzZUclgybWxyeFRLNTI5dzZQc2xsb09FLWZRN3hyZmhaR2F5dG9oeDlqZkZaUGlVWHk2enM4NFF0Sm9RcUc1azZleGFJdkpOWnFDWkVLQXBaQXZfY3NTRXlUY3FKZkxpR0d0aVdhRlNMUW5FSFBXcUw4elVNN1hld1BjSTVhR2l6M0lxQlVTOGVyR1BrYmhJUlVy?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-06-25T17:23:33+00:00", "published_display": "25 Jun 2026 17:23", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPTWJIQUNtUi1jc2NZVEZCdjY5amFSZHJzV1didzB2bGgxSWFYVlRMeDFQRG8xS01qWlRHWmlYTDUwdEVETTI4NXRNRWgwYmI2QlVDang3aVg4VFByOW5URXpnb1dVVjZQVC05bk5mODJRNzdCSDU1Q2hoX2ZjN21OZlROeXZjU2JZWjFRQ191SVU4ZkRERFNv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "StockTake: Imagion Biosystems", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Issues 6.2 Million Performance Rights to Directors Under Shareholder-Approved Incentive Scheme", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxOTTAzLWZrLXhiazZJRm9MZ1NnYlFTNW1MaWdyTVVmNkdTRGJLbFBVcFVNR0tKNHkyeENoVVBsVUhwNnBvemVfTzAyRl9fUElfa3o0VXFMR1JaR2l4dzZVaExUNmc4bG9EM3ZJSjU2TXhWSGwyazBoWUp2MHFMVnJ5US10MkJ0ZGZ3OVNxaS1XdFhqLU1kQVdrNzdoWUtzckdINmxMWVJGUnNsOTNCMy1ydUl3NDYwdnRmZ0lSNW93eDY4WFRJcndEOVVPXzlPbUliTjF1UHlLUGpXcjZPUU50QzRFVnN0d3gyWVE?oc=5", "source_name": "Kalkine", "published_at": "2026-06-25T05:27:47+00:00", "published_display": "25 Jun 2026 05:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems\u2019 IND Application for MagSense\u00ae Phase 2 Clinical Trial Clears FDA Review", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOSnRUanBLZjBqTXpGV3psWWFaTlZfYUI2ZjVGNFRKUDI2MEFzTlg0MmJMNDZrV2s4NDNfVEZNc2V0VEV5Um1uVllndWNzd2NGeE03MEo4dDFCLTdfa3pXT2lNNE9VYnZObUxwcFo3bzQ3X2U1ZjloN3JjVDFudkxuMllMS1RmSUtJU3Uzb2pTU3RFdTItVlBodVNQeVhRWENrd3JDbUhyclo5ZU9ORTB3eUk0VUo2b1Y5TXpFMFpNVGZkMGlpUWxYcFp2VFVIeVZFSHZEc3pERWlaOWJRblE?oc=5", "source_name": "Business Wire", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion receives FDA trial clearance", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems (ASX:IBX) gets FDA green light for HER2 trial, recruitment starts Q3", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5idGNSVkVmaUlBbjlIUlE2RlE0VXNfbEI1Z3dUQ1UxUjdBNVhfUVhZdHNhejRfLXM0dno0YzJZc2VUUDN1dnFUbzFaSzNnMGEwNEM1RldobW4ycG1xNEZienJ2ZjJlaWVxVk93OUphSFZfdEdNdFRXZkZ2NGg?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: 333D, Imagion Biosciences, Zenith & Locksley", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQb1poT0ZtTUtCNTM4MGJrNDk3VjlySnNMTzluaURFMnZ3TnFXMUIzekxXMjc2OGZEYTM1WHZIY2xSdVVOeHZXTjk5X1hIeWJNS21yODM1YUxiYV9ic1Q0RDk2TnFhYV9ZbHdBdFBheFY3Tzh0eWYwd2QyUFE0WjhiVENzMUg3dmlaMEZIdHpkb0gzcWxjNktOLWYwVDlWQ1c3LU1kTkVTSVBNZlBDVWVwODkyY0RxZFM4aTNZQ3JYSUY4Y2pEdURLLTdQRQ?oc=5", "source_name": "SMH.com.au", "published_at": "2025-09-12T07:00:00+00:00", "published_display": "12 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems (ASX:IBX) is getting ready for a Phase 2 study: Interview with Chair Bob Proulx", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFAzbFpySEoxQnVIZm5CQktfc252eGR6Q25SUGxQcHVGdjR0TTAzLWZTV0NYT3hVUVVRWk41bENSZngyVHYyYmpUTjVVZFVNUHFUaDFYZ3pkSGRleWppc01FdmlDZXNMQjlPZGphSkJtTUNwVWprVXNQdUxpZw?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-08-10T07:00:00+00:00", "published_display": "10 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems (ASX:IBX) gets ready for Phase 2", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE11QTJPTjF3T00wUmJWNHdDcTFhT0dZS1lPdUdnQ1JaVG51dmxMSHdiZ2dzNW9UbDFDMjVfcFljWHJkcXdkZHFiS01HVGRZRDRRdEtza2tpRzhfRzF6YS12Yl9BNmpfUXIwVmNlMUlDNkVvQW1WLUdGOUZiQnQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-08-04T05:41:59+00:00", "published_display": "04 Aug 2025 05:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Imagion Biosystems (ASX:IBX) share price just exploded by 60%. Here's why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPNnBIRmxmY29fenpKUlU2dENwVjQ2dDNzT3hwaXplR0Q1SFRxTkgyTTNPOXY1Mm13S3RjWlJKMmNVam9PN296QWZGaVlBRDFUM29qcGZwbzE3Mk9mX1lRMEhuZ3luZmc4TnoxeVdYLThscWJYeHJROWNfZjlRbnpGRHJHVEZWWXdKVHJ5aTBSMGlQdUJxaWx0TGt3U0FvRmxkcVJJVnhPT2k3Q28?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2022-03-17T07:00:00+00:00", "published_display": "17 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Hopeful That Imagion Biosystems (ASX:IBX) Will Use Its Cash Wisely", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNaTFUUDNDQkFaVXJRMWdyUUc2MnA1SXFIWkdjY1NQUjRpdV9JMVdpSGIyeFdKZU5IMlBlXzllcFpfV2s5ektReFA0QkI2RG55OXNzTkZSQWN2ODVuNG52SEJYYUpMNmZibFVtVXJxODFrMF9mWkVoTWkwOFFMdDlkZXd5eWtHZDFkUURZUHdZeTNpUmc0OEZXTjM3MHczTjE1dnZoUGtn?oc=5", "source_name": "Kalkine", "published_at": "2021-11-06T07:00:00+00:00", "published_display": "06 Nov 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Limited (ASX: IBX) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPR3d4RjVFd05iTnlFQjhtUjVrWTRsQlI1UFk1RTlka05rcEFFM01LV0dIVjVWNGxlVkhINmw5VUlUMThaeFZRbWdIbVY5UHBxRXV2ZUg1SEJtWXFUMTl1QnZ3czQxWFhWYnlsajdGMEZJcG9YSU01MmF1dTJWRnhfbEM1eUM2WWlsMlhBbDh3LWJLYll4YWNj?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-19T21:54:54+00:00", "published_display": "19 Feb 2020 21:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Limited (ASX: IBX) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNUXpfVGM4MU1COHFZOVFLaDBwZ3BsLW9wUXBGQzRNQnQwSDVNNHpkMFRQMldfZU9Odm1KRWUxLWZkQ0JZUGJhVzhKTU5memxxMVhTZENNVzd6UUw5a1FUdW5DTlJnMEh3SzhEMm9OdDhfYW5VNE9CYVFpMUxwa2ZwNmdXbVVJS3VHR0p2alZDSWpKQW4yM0pyTjNn?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-10-09T09:30:42+00:00", "published_display": "09 Oct 2019 09:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBX Stock Price and Chart \u2014 ASX:IBX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBhYXZrMVE4UUJNOU1kUXY5akc3OEh5MVJDbzdNTUFtYjctUjB5akZWTXQ4QlpmNnREbHVIUjZTd2NFdDJGVHdBX1RrUmpOWVAzejhLSGpTVQ?oc=5", "source_name": "TradingView", "published_at": "2017-07-23T14:02:51+00:00", "published_display": "23 Jul 2017 14:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Is Imagion Biosystems Ltd (ASX: IBX) an ASX MedTech Stock to Watch?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNd0R6aDlUVHphVnZZNmtoODlWU3NrcFMzZ19iVEprQkhONTJrdXhLaXA2aDNhOTVvT3RDZTBTZ1JIVWFwT25qOTBxYVBwNk5ZbmRsNlVtMTF0Z0hmWlJiZ2pjM2l0TGFPSmVDeG81dl9xbTNwYy1yaEdONHdtQ2hnZUpjV1ZnUEFTNDdRNWQ3NVVucC13Y0lPckRTcjRaV25FOUN3VQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-14T03:26:00+00:00", "published_display": "14 Jul 2026 03:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Raises AU$3.75M; Extends Siemens Partnership to Advance Breast Cancer Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOd1NKQW9vV3p0ZmZ0OGZxR21KdlpqMUNPdjlORG9NN3UydHRUck9tZm1MU2ItcVdBbGVHRnE5WFRxRTc0R0JKOGxmeEpGdERhcHpfVl95b0NacVBGWkxtYXEzTGVIUnZDT1dTT2Rld3RWZ1FyTnJBb3hXbVktcWRRUzVlX3VmaWFzMFhCY0Y2OVdpSFQ3cTVfUEU4NnlOd3RVSk1kOTR4d005X3NOTzlBcUtGVGV5NzlNZ0VfTA?oc=5", "source_name": "Femtech Insider", "published_at": "2026-07-10T06:38:56+00:00", "published_display": "10 Jul 2026 06:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Completes Placement of 49.3 Million Shares at $0.012, Bringing Total Ordinary Shares on Issue to 539.9 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxNNi05SU1rejFkbzh5ZnJpeDFyRGZnWEtGdzhtTGJGUW51cTc3b0h5QVZia25YUV9Cd3k0X3EzSENDMWdPeTkwN3NJMlNnaUtBX1BwdThRcWktc2h4WWNXb3hFeW9lRUphbmxwb0RVV0I1SWFKZVhkYUZRUEtiRXZvZlp6dDlYWjA4UFk0dTdNZjBxZnQtd3VEVE1pbkt3QkdNTDVULVU4Q0loeDF3aDNoRnF5NVJMSkhxZTl0Zk1zQWxvOE45OUh3c1I4dU9rU1lpbTNSdkd3U3RHOWo1NFBkVVVOTnl1OWx1N3N0ejU2ZVpfMWtBRWNhRWJR?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Issues 49.3 Million Shares at 1.2 Cents Each in Tranche 1 Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNVlM2QTVjQzZvR3h4ZWlMc3plc3ZCLVJwd3RDR1g2VjdWdFNNb0QwZVFRemZ2TS1vSlBrYmhHdkgzQlI0c0xiX1VsdjhXUklXQzZHX3JpdVNndUtfOUdBUlptYUxyakR3S0FaMUlFUGxKOU9uZVZ3VFlNeV9JSkZDbW1pamxhdVZmV3RMYnlBUjJFMzlYckVsTTJHdmZMUThTZXd4V0xnZ1BqWWVMUmNIT2pkSy1OSjU3a0ptemdaSmhQc2Jy?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T05:26:40+00:00", "published_display": "02 Jul 2026 05:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Imagion Biosystems (ASX:IBX) Attracting Medtech Investors?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPQ0ptdmM5T2NBT1ZlVmF3Z2xlUkphU0V6eHdPeEIwd0wtU1JHVTNqNXhLT09kM2RmVmgtcFUzNE83bUxHZnhaNGc1QzBBRFd6cnplR0FQMlBud2wxNjVpaG4tRUE1bTJpTTQ0QTluUVVUWFotZ2xNRzhvalMwZXB4b1JMdERPODZsWlRETE9CLWJOeXV4cndhN0psdE1zQ01OVG1Seg?oc=5", "source_name": "Kalkine", "published_at": "2026-06-29T13:49:00+00:00", "published_display": "29 Jun 2026 13:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Secures AU$3.75 Million Capital Raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNSjJQdVp0TFBJdVRfS2c5N0RlWXpFNjlENk1tZy1BU29pT1AwTUlhT2JPWDlzUW5ILVQ0cUJhSlBPUzRBckdhYjN5eDZPaDc1ZHVFa01WNEktR3NMWlFTYzk4N2tWQjRnMTVXLVltUVJGY1dTeDluTFFrMVk1bHBvUtIBhgFBVV95cUxQV2NSdmp5Z3VibW12cm1ZZGluME1wYW9CX29YVV9qdmx3QjNCOENPTEZ2dGtrVGY0TnVoMDFiQVZoYnRFTVhwMkhjaVUzZ2V0bzhORlFueklvNG04M2hWRk04VGxVblZwWVppTU04bjY2c2psQkVfampxT0U0bDhEZFlRNVd5UQ?oc=5", "source_name": "Pulse 2.0", "published_at": "2026-06-26T12:23:12+00:00", "published_display": "26 Jun 2026 12:23", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems raises AU$3.75M for breast cancer trial By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVlFFR1ZQWlNUd0NNWkFKWnZSbVFQX2VMb1hySjA2UzZUclgybWxyeFRLNTI5dzZQc2xsb09FLWZRN3hyZmhaR2F5dG9oeDlqZkZaUGlVWHk2enM4NFF0Sm9RcUc1azZleGFJdkpOWnFDWkVLQXBaQXZfY3NTRXlUY3FKZkxpR0d0aVdhRlNMUW5FSFBXcUw4elVNN1hld1BjSTVhR2l6M0lxQlVTOGVyR1BrYmhJUlVy?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-06-25T17:23:33+00:00", "published_display": "25 Jun 2026 17:23", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPTWJIQUNtUi1jc2NZVEZCdjY5amFSZHJzV1didzB2bGgxSWFYVlRMeDFQRG8xS01qWlRHWmlYTDUwdEVETTI4NXRNRWgwYmI2QlVDang3aVg4VFByOW5URXpnb1dVVjZQVC05bk5mODJRNzdCSDU1Q2hoX2ZjN21OZlROeXZjU2JZWjFRQ191SVU4ZkRERFNv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "StockTake: Imagion Biosystems", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Issues 6.2 Million Performance Rights to Directors Under Shareholder-Approved Incentive Scheme", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxOTTAzLWZrLXhiazZJRm9MZ1NnYlFTNW1MaWdyTVVmNkdTRGJLbFBVcFVNR0tKNHkyeENoVVBsVUhwNnBvemVfTzAyRl9fUElfa3o0VXFMR1JaR2l4dzZVaExUNmc4bG9EM3ZJSjU2TXhWSGwyazBoWUp2MHFMVnJ5US10MkJ0ZGZ3OVNxaS1XdFhqLU1kQVdrNzdoWUtzckdINmxMWVJGUnNsOTNCMy1ydUl3NDYwdnRmZ0lSNW93eDY4WFRJcndEOVVPXzlPbUliTjF1UHlLUGpXcjZPUU50QzRFVnN0d3gyWVE?oc=5", "source_name": "Kalkine", "published_at": "2026-06-25T05:27:47+00:00", "published_display": "25 Jun 2026 05:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems\u2019 IND Application for MagSense\u00ae Phase 2 Clinical Trial Clears FDA Review", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOSnRUanBLZjBqTXpGV3psWWFaTlZfYUI2ZjVGNFRKUDI2MEFzTlg0MmJMNDZrV2s4NDNfVEZNc2V0VEV5Um1uVllndWNzd2NGeE03MEo4dDFCLTdfa3pXT2lNNE9VYnZObUxwcFo3bzQ3X2U1ZjloN3JjVDFudkxuMllMS1RmSUtJU3Uzb2pTU3RFdTItVlBodVNQeVhRWENrd3JDbUhyclo5ZU9ORTB3eUk0VUo2b1Y5TXpFMFpNVGZkMGlpUWxYcFp2VFVIeVZFSHZEc3pERWlaOWJRblE?oc=5", "source_name": "Business Wire", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion receives FDA trial clearance", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems (ASX:IBX) gets FDA green light for HER2 trial, recruitment starts Q3", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE5idGNSVkVmaUlBbjlIUlE2RlE0VXNfbEI1Z3dUQ1UxUjdBNVhfUVhZdHNhejRfLXM0dno0YzJZc2VUUDN1dnFUbzFaSzNnMGEwNEM1RldobW4ycG1xNEZienJ2ZjJlaWVxVk93OUphSFZfdEdNdFRXZkZ2NGg?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: 333D, Imagion Biosciences, Zenith & Locksley", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQb1poT0ZtTUtCNTM4MGJrNDk3VjlySnNMTzluaURFMnZ3TnFXMUIzekxXMjc2OGZEYTM1WHZIY2xSdVVOeHZXTjk5X1hIeWJNS21yODM1YUxiYV9ic1Q0RDk2TnFhYV9ZbHdBdFBheFY3Tzh0eWYwd2QyUFE0WjhiVENzMUg3dmlaMEZIdHpkb0gzcWxjNktOLWYwVDlWQ1c3LU1kTkVTSVBNZlBDVWVwODkyY0RxZFM4aTNZQ3JYSUY4Y2pEdURLLTdQRQ?oc=5", "source_name": "SMH.com.au", "published_at": "2025-09-12T07:00:00+00:00", "published_display": "12 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems (ASX:IBX) is getting ready for a Phase 2 study: Interview with Chair Bob Proulx", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFAzbFpySEoxQnVIZm5CQktfc252eGR6Q25SUGxQcHVGdjR0TTAzLWZTV0NYT3hVUVVRWk41bENSZngyVHYyYmpUTjVVZFVNUHFUaDFYZ3pkSGRleWppc01FdmlDZXNMQjlPZGphSkJtTUNwVWprVXNQdUxpZw?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-08-10T07:00:00+00:00", "published_display": "10 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems (ASX:IBX) gets ready for Phase 2", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE11QTJPTjF3T00wUmJWNHdDcTFhT0dZS1lPdUdnQ1JaVG51dmxMSHdiZ2dzNW9UbDFDMjVfcFljWHJkcXdkZHFiS01HVGRZRDRRdEtza2tpRzhfRzF6YS12Yl9BNmpfUXIwVmNlMUlDNkVvQW1WLUdGOUZiQnQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-08-04T05:41:59+00:00", "published_display": "04 Aug 2025 05:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Imagion Biosystems (ASX:IBX) share price just exploded by 60%. Here's why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPNnBIRmxmY29fenpKUlU2dENwVjQ2dDNzT3hwaXplR0Q1SFRxTkgyTTNPOXY1Mm13S3RjWlJKMmNVam9PN296QWZGaVlBRDFUM29qcGZwbzE3Mk9mX1lRMEhuZ3luZmc4TnoxeVdYLThscWJYeHJROWNfZjlRbnpGRHJHVEZWWXdKVHJ5aTBSMGlQdUJxaWx0TGt3U0FvRmxkcVJJVnhPT2k3Q28?oc=5", "source_name": "The Motley Fool Australia", "published_at": "2022-03-17T07:00:00+00:00", "published_display": "17 Mar 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Hopeful That Imagion Biosystems (ASX:IBX) Will Use Its Cash Wisely", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNaTFUUDNDQkFaVXJRMWdyUUc2MnA1SXFIWkdjY1NQUjRpdV9JMVdpSGIyeFdKZU5IMlBlXzllcFpfV2s5ektReFA0QkI2RG55OXNzTkZSQWN2ODVuNG52SEJYYUpMNmZibFVtVXJxODFrMF9mWkVoTWkwOFFMdDlkZXd5eWtHZDFkUURZUHdZeTNpUmc0OEZXTjM3MHczTjE1dnZoUGtn?oc=5", "source_name": "Kalkine", "published_at": "2021-11-06T07:00:00+00:00", "published_display": "06 Nov 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Limited (ASX: IBX) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPR3d4RjVFd05iTnlFQjhtUjVrWTRsQlI1UFk1RTlka05rcEFFM01LV0dIVjVWNGxlVkhINmw5VUlUMThaeFZRbWdIbVY5UHBxRXV2ZUg1SEJtWXFUMTl1QnZ3czQxWFhWYnlsajdGMEZJcG9YSU01MmF1dTJWRnhfbEM1eUM2WWlsMlhBbDh3LWJLYll4YWNj?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-19T21:54:54+00:00", "published_display": "19 Feb 2020 21:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Imagion Biosystems Limited (ASX: IBX) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNUXpfVGM4MU1COHFZOVFLaDBwZ3BsLW9wUXBGQzRNQnQwSDVNNHpkMFRQMldfZU9Odm1KRWUxLWZkQ0JZUGJhVzhKTU5memxxMVhTZENNVzd6UUw5a1FUdW5DTlJnMEh3SzhEMm9OdDhfYW5VNE9CYVFpMUxwa2ZwNmdXbVVJS3VHR0p2alZDSWpKQW4yM0pyTjNn?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-10-09T09:30:42+00:00", "published_display": "09 Oct 2019 09:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IBX Stock Price and Chart \u2014 ASX:IBX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBhYXZrMVE4UUJNOU1kUXY5akc3OEh5MVJDbzdNTUFtYjctUjB5akZWTXQ4QlpmNnREbHVIUjZTd2NFdDJGVHdBX1RrUmpOWVAzejhLSGpTVQ?oc=5", "source_name": "TradingView", "published_at": "2017-07-23T14:02:51+00:00", "published_display": "23 Jul 2017 14:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 86, "total_relevant": 21, "sentiment_summary": {"positive": 4, "negative": 0, "neutral": 17, "score": 53, "total": 21, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 10.45, "count": 19}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.01, "latest_week": "2026-07-10", "one_week_move": 9.1, "four_week_move": -25.0, "twelve_week_move": -45.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.330274, "market_dynamics_buy_signal": false, "relative_strength": -44.122274, "fair_value_gap": -89.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 25.9337, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+9.1% over one week, -25.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 6}, {"label": "Stocks Down Under", "count": 3}, {"label": "The Australian", "count": 2}, {"label": "intelligentinvestor.com.au", "count": 2}, {"label": "Femtech Insider", "count": 1}, {"label": "Pulse 2.0", "count": 1}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "Market source", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 21}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 19}, {"label": "Deals and strategy", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "21", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+9.1% over one week, -25.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Is Imagion Biosystems Ltd (ASX: IBX) an ASX MedTech Stock to Watch?"}], "updated_at": "2026-07-17T06:25:30.642954+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}